Literature DB >> 7049213

alpha-Methyldopa, alpha-methyldopamine an alpha-methylnoradrenaline: substrates for the thermolabile form of human platelet phenol sulphotransferase.

G Mwaluko, R Weinshilboum.   

Abstract

1 Sulphate conjugation catalyzed by phenol sulphotransferase (PST) is an important pathway in the catabolism of alpha-methyldopa (MD). Variations in PST activity in an easily obtained tissue such as the human platelet might reflect individual differences in the sulphate conjugation of MD in other organs and tissues. There are at least two forms of human platelet PST, a thermolabile form for which dopamine is a substrate and a thermostable form for which low concentrations of phenol can serve as a substrate. 2 MD, alpha-methyldopamine (MDA) and alpha-methylnoradrenaline (MNA) were tested as substrates for human platelet PST. All three were substrates for the thermolabile form of the enzyme and none were substrates for the thermostable form of PST. Apparent Michaelis-Menten (Km) values for MD, MDA and MNA were 5.5, 0.014 and 0.28 mM, respectively. Apparent Km values for 3'-phosphoadenosine-5'-phosphosulphate, the sulphate donor for the reaction, were 0.08, 0.13 and 0.10 microM, respectively, for the three catechol substrates. The pH optima for the reaction were 7.5 for MD and 6.5 for both MDA and MNA. 3 When platelet homogenates from 20 individual subjects were tested, there were significant correlations between PST activities measured with dopamine and those measured with MD, MDA and MNA (r = 0.54, 0.98 and 0.93, P less than 0.02, less than 0.001, and less than 0.001, respectively), but not between activities measured with low concentrations of phenol and those measured with MD, MDA and MNA (r = 0.021, 0.045 and 0.046, respectively). There results were also compatible with the conclusion that MD, MDA and MNA were substrates for the thermolabile form of platelet PST. 4 These observations will make it possible to test the hypothesis that variations in the activity of the thermolabile form of platelet PST may reflect individual differences in the sulphate conjugation of MD, MDA and MNA.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7049213      PMCID: PMC1427737          DOI: 10.1111/j.1365-2125.1982.tb01967.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  16 in total

1.  Computer programmes for processing enzyme kinetic data.

Authors:  W W CLELAND
Journal:  Nature       Date:  1963-05-04       Impact factor: 49.962

2.  Statistical estimations in enzyme kinetics.

Authors:  G N WILKINSON
Journal:  Biochem J       Date:  1961-08       Impact factor: 3.857

3.  The inactivation of adrenaline in vivo in man.

Authors:  D Richter
Journal:  J Physiol       Date:  1940-07-24       Impact factor: 5.182

4.  Pharmacokinetics of acetaminophen in the human neonate: formation of acetaminophen glucuronide and sulfate in relation to plasma bilirubin concentration and D-glucaric acid excretion.

Authors:  G Levy; N N Khanna; D M Soda; O Tsuzuki; L Stern
Journal:  Pediatrics       Date:  1975-06       Impact factor: 7.124

5.  Pharmacokinetics of methyldopa in healthy man.

Authors:  O Stenbaek; E Myhre; H E Rugstad; E Arnold; T Hansen
Journal:  Eur J Clin Pharmacol       Date:  1977-10-14       Impact factor: 2.953

6.  Rat brain phenolsulfotransferase: partial purification and some properties.

Authors:  A Foldes; J L Meek
Journal:  Biochim Biophys Acta       Date:  1973-12-19

7.  Conjugation of methyldopa in renal failure.

Authors:  E Myhre; O Stenbaek; E K Brodwall; T Hansen
Journal:  Scand J Clin Lab Invest       Date:  1972-04       Impact factor: 1.713

8.  Localization and characterization of phenol sulfotransferase in human platelets.

Authors:  R F Hart; K J Renskers; E B Nelson; J A Roth
Journal:  Life Sci       Date:  1979-01-08       Impact factor: 5.037

Review 9.  Central sympathetic transmitters and hypertension.

Authors:  M Henning
Journal:  Clin Sci Mol Med Suppl       Date:  1975-06

10.  Plasma concentration of alpha-methyldopa and sulphate conjugate after oral administration of methyldopa and intravenous administration of methyldopa and methyldopa hydrochloride ethyl ester.

Authors:  J A Saavedra; J L Reid; W Jordan; M D Rawlins; C T Dollery
Journal:  Eur J Clin Pharmacol       Date:  1975-08-14       Impact factor: 2.953

View more
  2 in total

1.  Sulphate conjugation of p-hydroxytriamterene by platelet phenol sulphotransferase: assay conditions and correlation with metabolism in man.

Authors:  C Reiter; P G Werness; J Van Loon; L H Smith; R M Weinshilboum
Journal:  Br J Clin Pharmacol       Date:  1983-02       Impact factor: 4.335

2.  Thermolabile and thermostable human platelet phenol sulfotransferase. Substrate specificity and physical separation.

Authors:  C Reiter; G Mwaluko; J Dunnette; J Van Loon; R Weinshilboum
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-09       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.